1887

Abstract

Antibiotic resistance of isolated from urinary tract infections (UTIs) is increasing worldwide. A total of 41 isolates were obtained from urine samples from hospitalized patients with a UTI in three hospitals in the northern districts of the West Bank, Palestine during March and June 2011. Resistance rates were: erythromycin (95 %), trimethoprim–sulfamethoxazole (59 %), ciprofloxacin (56 %), gentamicin (27 %), imipenem (22 %), amoxicillin (93 %), amoxicillin–clavulanic acid (32 %), ceftazidime (66 %) and cefotaxime (71 %). No meropenem-resistant isolates were identified in this study. Among the isolates, phylogenetic group B2 was observed in 13 isolates, D in 12 isolates, A in 11 isolates and B1 in five isolates. Thirty-five of the isolates were positive for an extended-spectrum β-lactamase phenotype. Among these isolates, the gene was detected in 25, and eight harboured the gene. None of the isolates contained the gene. Transformation experiments indicated that some of the β-lactamase genes (i.e. and ) with co-resistance to erythromycin and gentamicin were plasmid encoded and transmissible. Apart from this, enterobacterial repetitive intergenic consensus-PCR (ERIC-PCR) revealed that the 41 isolates were genetically diverse and comprised a heterogeneous population with 11 ERIC-PCR profiles at a 60 % similarity level.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.067140-0
2014-02-01
2021-03-06
Loading full text...

Full text loading...

/deliver/fulltext/jmm/63/2/229.html?itemId=/content/journal/jmm/10.1099/jmm.0.067140-0&mimeType=html&fmt=ahah

References

  1. Akpaka P. E., Legall B., Padman J. 2010; Molecular detection and epidemiology of extended-spectrum beta-lactamase genes prevalent in clinical isolates of Klebsiella pneumoniae and E. coli from Trinidad and Tobago. West Indian Med J 59:591–596[PubMed]
    [Google Scholar]
  2. Al-Assil B., Mahfoud M., Hamzeh A. R. 2013; Resistance trends and risk factors of extended-spectrum β-lactamases in Escherichia coli infections in Aleppo, Syria. Am J Infect Control 41:597–600 [CrossRef][PubMed]
    [Google Scholar]
  3. Baral P., Neupane S., Marasini B. P., Ghimire K. R., Lekhak B., Shrestha B. 2012; High prevalence of multidrug resistance in bacterial uropathogens from Kathmandu, Nepal. BMC Res Notes 5:38 [CrossRef][PubMed]
    [Google Scholar]
  4. Chakupurakal R., Ahmed M., Sobithadevi D. N., Chinnappan S., Reynolds T. 2010; Urinary tract pathogens and resistance pattern. J Clin Pathol 63:652–654 [CrossRef][PubMed]
    [Google Scholar]
  5. CLSI. 2013; Performance Standards for Antimicrobial Susceptibility Testing; 23rd Informational Supplement M100-S23. Wayne, PA: Clinical and Laboratory Standards Institute;
  6. Harley J. P., Prescott L. M. 2002 Laboratory Exercises in Microbiology, 5th edn. pp. 37–237 Boston, MA: McGraw-Hill Publishers;
    [Google Scholar]
  7. Karlowsky J. A., Lagacé-Wiens P. R., Simner P. J., DeCorby M. R., Adam H. J., Walkty A., Hoban D. J., Zhanel G. G. 2011; Antimicrobial resistance in urinary tract pathogens in Canada from 2007 to 2009: CANWARD surveillance study. Antimicrob Agents Chemother 55:3169–3175 [CrossRef][PubMed]
    [Google Scholar]
  8. Khanna N., Boyes J., Lansdell P. M., Hamouda A., Amyes S. G. 2012; Molecular epidemiology and antimicrobial resistance pattern of extended-spectrum-β-lactamase-producing Enterobacteriaceae in Glasgow, Scotland. J Antimicrob Chemother 67:573–577 [CrossRef][PubMed]
    [Google Scholar]
  9. Lee S., Yu J. K., Park K., Oh E. J., Kim S. Y., Park Y. J. 2010; Phylogenetic groups and virulence factors in pathogenic and commensal strains of Escherichia coli and their association with blaCTX-M. Ann Clin Lab Sci 40:361–367[PubMed]
    [Google Scholar]
  10. Leflon-Guibout V., Jurand C., Bonacorsi S., Espinasse F., Guelfi M. C., Duportail F., Heym B., Bingen E., Nicolas-Chanoine M. H. 2004; Emergence and spread of three clonally related virulent isolates of CTX-M-15-producing Escherichia coli with variable resistance to aminoglycosides and tetracycline in a French geriatric hospital. Antimicrob Agents Chemother 48:3736–3742 [CrossRef][PubMed]
    [Google Scholar]
  11. Livermore D. M., Hawkey P. M. 2005; CTX-M: changing the face of ESBLs in the UK. J Antimicrob Chemother 56:451–454 [CrossRef][PubMed]
    [Google Scholar]
  12. Ma K. L., Wang C. X. 2013; Analysis of the spectrum and antibiotic resistance of uropathogens in vitro: results based on a retrospective study from a tertiary hospital. Am J Infect Control 41:601–606 [CrossRef][PubMed]
    [Google Scholar]
  13. Mendonça N., Leitão J., Manageiro V., Ferreira E., Caniça M. 2007; Spread of extended-spectrum β-lactamase CTX-M-producing Escherichia coli clinical isolates in community and nosocomial environments in Portugal. Antimicrob Agents Chemother 51:1946–1955 [CrossRef][PubMed]
    [Google Scholar]
  14. Mukherjee M., Basu S., Mukherjee S. K., Majumder M. 2013; Multidrug-resistance and extended spectrum beta-lactamase production in uropathogenic E. coli which were isolated from hospitalized patients in Kolkata, India. J Clin Diagn Res 7:449–453[PubMed]
    [Google Scholar]
  15. Murugan K., Savitha T., Vasanthi S. 2012; Retrospective study of antibiotic resistance among uropathogens from rural teaching hospital, Tamilnadu, India. Asian Pac J Trop Dis 2:375–380 [CrossRef]
    [Google Scholar]
  16. Naseer U., Sundsfjord A. 2011; The CTX-M conundrum: dissemination of plasmids and Escherichia coli clones. Microb Drug Resist 17:83–97 [CrossRef][PubMed]
    [Google Scholar]
  17. Peirano G., Pitout J. D. 2010; Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25 : H4. Int J Antimicrob Agents 35:316–321 [CrossRef][PubMed]
    [Google Scholar]
  18. Pitout J. D., Laupland K. B., Church D. L., Menard M. L., Johnson J. R. 2005; Virulence factors of Escherichia coli isolates that produce CTX-M-type extended-spectrum beta-lactamases. Antimicrob Agents Chemother 49:4667–4670 [CrossRef][PubMed]
    [Google Scholar]
  19. Rakotonirina H. C., Garin B., Randrianirina F., Richard V., Talarmin A., Arlet G. 2013; Molecular characterization of multidrug-resistant extended-spectrum β-lactamase-producing Enterobacteriaceae isolated in Antananarivo, Madagascar. BMC Microbiol 13:85 [CrossRef][PubMed]
    [Google Scholar]
  20. Smet A., Martel A., Persoons D., Dewulf J., Heyndrickx M., Claeys G., Lontie M., Van Meensel B., Herman L.& other authors ( 2010; Characterization of extended-spectrum β-lactamases produced by Escherichia coli isolated from hospitalized and non-hospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections. Microb Drug Resist 16:129–134 [CrossRef][PubMed]
    [Google Scholar]
  21. Takahashi S., Nagano Y. 1984; Rapid procedure for isolation of plasmid DNA and application to epidemiological analysis. J Clin Microbiol 20:608–613[PubMed]
    [Google Scholar]
  22. Vaidya V. K. 2011; Horizontal transfer of antimicrobial resistance by extended-spectrum β lactamase-producing Enterobacteriaceae.. J Lab Physicians 3:37–42 [CrossRef][PubMed]
    [Google Scholar]
  23. Wollheim C., Guerra I. M. F., Conte V. D., Hoffman S. P., Schreiner F. J., Delamare A. P. L., Barth A. L., Echeverrigaray S., da Costa S. O. P. 2011; Nosocomial and community infections due to class A extended-spectrum β-lactamase (ESBLA)-producing Escherichia coli and Klebsiella spp. in southern Brazil. Braz J Infect Dis 15:138–143[PubMed]
    [Google Scholar]
  24. Xiao Y. H., Giske C. G., Wei Z. Q., Shen P., Heddini A., Li L. J. 2011; Epidemiology and characteristics of antimicrobial resistance in China. Drug Resist Updat 14:236–250 [CrossRef][PubMed]
    [Google Scholar]
  25. Zhang Y., Yang J., Ye L., Luo Y., Wang W., Zhou W., Cui Z., Han L. 2012; Characterization of clinical multidrug-resistant Escherichia coli and Klebsiella pneumoniae isolates, 2007-2009, China. Microb Drug Resist 18:465–470 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.067140-0
Loading
/content/journal/jmm/10.1099/jmm.0.067140-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error